Hosted on MSN2d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved
This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...
FiercePharma1d
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
MyChesCo on MSN5d
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment
The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
McKnight's Long-Term Care News4d
FDA approves first generic liraglutide once-daily injection
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
Seeking Alpha on MSN1d
Novo Nordisk seeks to block compounded Victoza
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Drug Store News2d
Hikma gets FDA nod for generic Victoza, launches 2 new generics
Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...
JD Supra1d
FDA Announced Removal of Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...
Managed Healthcare Executive11d
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
MedPage Today12d
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
CNN12d
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
Liraglutide has been in shortage in the US since July 2023, according to an FDA database. The agency, in its Monday announcement, noted it “prioritizes assessment of generic drug applications ...